CA2009221A1 - Preparations en aerosol pour traiter les infections respiratoires - Google Patents

Preparations en aerosol pour traiter les infections respiratoires

Info

Publication number
CA2009221A1
CA2009221A1 CA2009221A CA2009221A CA2009221A1 CA 2009221 A1 CA2009221 A1 CA 2009221A1 CA 2009221 A CA2009221 A CA 2009221A CA 2009221 A CA2009221 A CA 2009221A CA 2009221 A1 CA2009221 A1 CA 2009221A1
Authority
CA
Canada
Prior art keywords
respiratory tract
tract infections
spray preparations
zinc
spray
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2009221A
Other languages
English (en)
Other versions
CA2009221C (fr
Inventor
Derek Bryce-Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kappa Pharmaceuticals Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2009221A1 publication Critical patent/CA2009221A1/fr
Application granted granted Critical
Publication of CA2009221C publication Critical patent/CA2009221C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002009221A 1989-02-02 1990-02-02 Preparations en aerosol pour traiter les infections respiratoires Expired - Fee Related CA2009221C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898902300A GB8902300D0 (en) 1989-02-02 1989-02-02 Antirhinoviral preparations
GB8902300.6 1989-02-02

Publications (2)

Publication Number Publication Date
CA2009221A1 true CA2009221A1 (fr) 1990-08-02
CA2009221C CA2009221C (fr) 2000-10-17

Family

ID=10651009

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002009221A Expired - Fee Related CA2009221C (fr) 1989-02-02 1990-02-02 Preparations en aerosol pour traiter les infections respiratoires

Country Status (11)

Country Link
US (1) US5622724A (fr)
EP (1) EP0381522B1 (fr)
JP (1) JPH03197430A (fr)
AT (1) ATE132747T1 (fr)
AU (1) AU652337B2 (fr)
CA (1) CA2009221C (fr)
DE (1) DE69024672T2 (fr)
ES (1) ES2080787T3 (fr)
GB (1) GB8902300D0 (fr)
IE (1) IE71664B1 (fr)
NZ (1) NZ232356A (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8916625D0 (en) 1989-07-20 1989-09-06 Bryce Smith Derek Respiratory tract spray preparations
DE4205828A1 (de) * 1992-02-26 1993-09-02 Henkel Kgaa Viruswirksame desinfektionsmittel
RU2121347C1 (ru) * 1996-12-15 1998-11-10 Закрытое акционерное общество Акционерная внешнеэкономическая компания "ЭКСИМА" Лекарственный препарат
US6171611B1 (en) 1997-11-12 2001-01-09 Dante J. Picciano Iodine-containing nasal moisturizing saline and mouthwash solutions
US5897872A (en) * 1997-11-12 1999-04-27 Picciano; Dante J. Iodine-containing nasal moisturizing saline solution
ES2136033B1 (es) * 1997-12-10 2000-05-16 Tudela Bernardo Hernandez Producto contra el resfriado con compuestos de zinc
GB9806937D0 (en) 1998-03-31 1998-05-27 Procter & Gamble A spray device
US6080783A (en) 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
US20040033260A1 (en) * 1999-10-19 2004-02-19 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
US20040234457A1 (en) * 1999-10-19 2004-11-25 The Procter & Gamble Company Methods of preventing and treating SARS using low pH respiratory tract compositions
US9072753B1 (en) * 2000-04-03 2015-07-07 Amy C. Brown Gargle method to reduce the duration of common cold symptoms
US20030215491A1 (en) * 2001-04-30 2003-11-20 Hensley Charles B. Method and composition for rapid delivery of bioactive compounds to the systemic circulation via the nasal membrane
US6929800B2 (en) * 2001-08-06 2005-08-16 Abdul Rasoul Salman Nasal passage cleaning composition
NL1020832C2 (nl) * 2002-06-12 2003-12-15 P K Benelux B V Farmaceutische samenstelling voor nasale toediening met een zinkverbinding, en toepassing.
WO2004024225A1 (fr) * 2002-09-16 2004-03-25 Zicam, Llc. Systeme et procede permettant d'administrer une composition a la membrane nasale
US7524517B2 (en) * 2003-01-17 2009-04-28 Uab Research Foundation Methods and compositions for P2X receptor calcium entry channels and other calcium entry mechanisms
US20040180006A1 (en) * 2003-03-12 2004-09-16 Sceusa Nicholas A. Methods and compositions for blocking the calcium cascade
US20070092583A1 (en) * 2003-04-30 2007-04-26 Tim Clarot Cold remedy composition comprising zinc salts
BRPI0518838A2 (pt) * 2004-12-09 2008-12-09 Dial Corp composiÇÕes tendo uma alta eficÁcia antiviral e antibactericida
WO2006062897A2 (fr) * 2004-12-09 2006-06-15 The Dial Corporation Compositions presentant une efficacite antivirale et antibacterienne elevee
US20080267904A1 (en) * 2004-12-09 2008-10-30 The Dial Corporation Compositions Having A High Antiviral And Antibacterial Efficacy
CA2588782A1 (fr) * 2004-12-09 2006-06-15 The Dial Corporation Compositions presentant une efficacite antivirale et antibacterienne elevee
US20090012174A1 (en) * 2004-12-09 2009-01-08 The Dial Corporation Compositions Having a High Antiviral and Antibacterial Efficacy
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
JP5038331B2 (ja) 2006-02-03 2012-10-03 ジェイアール ケム エルエルシー 銅と亜鉛の組成物を用いた老化防止治療
RU2008151178A (ru) * 2006-05-24 2010-06-27 Дзе Дайл Корпорейшн (Us) Способы и изделия, обладающие сильным противовирусным и противобактериальным действием
MX2008015088A (es) * 2006-05-26 2009-03-05 Dial Corp Metodo para inhibir la transmision de virus.
RU2008152402A (ru) * 2006-05-30 2010-07-10 Дзе Дайл Корпорейшн (Us) Композиции, обладающие сильным противовирусным действием
CA2653347A1 (fr) * 2006-05-31 2007-12-13 The Dial Corporation Preparations antimicrobiennes contenant de l'alcool d'efficacite amelioree
EP2034826A2 (fr) 2006-06-02 2009-03-18 The Dial Corporation Méthode destinée à inhiber la transmission du virus influenza
CA2653383A1 (fr) * 2006-06-05 2007-12-21 The Dial Corporation Procedes et articles ayant une efficacite antivirale et antibacterienne elevee
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US8513420B2 (en) * 2007-03-19 2013-08-20 Monika Mazik Amino-naphthyridine derivatives
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
WO2010085753A1 (fr) 2009-01-23 2010-07-29 Jr Chem, Llc Traitements pour l'acné rosacée et trousses médicales pour les mettre en pratique
US20150174137A1 (en) * 2010-06-02 2015-06-25 Alcon Research, Ltd. Compositions for treating microbial infections
CN103260623B (zh) * 2010-10-06 2016-11-02 伊斯塔制药公司 贝托斯汀组合物
JP5683719B2 (ja) 2011-01-04 2015-03-11 イスタ・ファーマシューティカルズ・インコーポレイテッドＩｓｔａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． ベポタスチン組成物
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US20180147140A1 (en) * 2016-11-30 2018-05-31 Darryl Thomas Finn Treatment and Prevention of ENT Infections
CN114159822A (zh) * 2020-08-20 2022-03-11 江苏正大丰海制药有限公司 一种药用级七水硫酸锌的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852432A (en) * 1971-01-18 1974-12-03 Department Of Health Education Diagnostic device and method of treatment
SE393532B (sv) * 1974-05-02 1977-05-16 Draco Ab Sett att framstella en farmaceutisk zinkberedning for astadkommande av en smaklig, fordragbar, peroral zinklosning innehallande ett zinkkomplex
US4255419A (en) * 1979-09-27 1981-03-10 Allergan Pharmaceuticals, Inc. Zinc deficiency in multiple sclerosis
US5002970A (en) * 1981-07-31 1991-03-26 Eby Iii George A Flavor masked ionizable zinc compositions for oral absorption
US4956385A (en) * 1981-07-31 1990-09-11 Eby Iii George A Method for reducing the duration of the common cold
US5409905A (en) * 1981-01-05 1995-04-25 Eby, Iii; George A. Cure for commond cold
US4503070A (en) * 1981-07-31 1985-03-05 Eby Iii George A Method for reducing the duration of the common cold
DE3431727A1 (de) * 1984-08-29 1986-03-13 Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen Nasenspray gegen schnupfen und grippe mit einem gehalt an zinkglukonat
DE3443985A1 (de) * 1984-12-01 1986-06-05 Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen Arzneimittelzubereitungen gegen mykotische und bakterielle infektionen mit einem gehalt an wirkstoffen, welche zink in ionisierter form freisetzen
US4814164A (en) * 1986-03-10 1989-03-21 Colgate-Palmolive Company Solid antitartar mouth deodorant composition
US4814163A (en) * 1986-03-10 1989-03-21 Colgate-Palmolive Company Solid antitartar mouth deodorant
US4946688A (en) * 1988-07-05 1990-08-07 Fahim Mostafa S Intraprostatic injection of zinc ions for treatment of inflammatory conditions and benign and malignant tumors of the prostate
GB8916625D0 (en) * 1989-07-20 1989-09-06 Bryce Smith Derek Respiratory tract spray preparations

Also Published As

Publication number Publication date
AU652337B2 (en) 1994-08-25
IE71664B1 (en) 1997-02-26
ES2080787T3 (es) 1996-02-16
ATE132747T1 (de) 1996-01-15
US5622724A (en) 1997-04-22
CA2009221C (fr) 2000-10-17
JPH03197430A (ja) 1991-08-28
EP0381522B1 (fr) 1996-01-10
IE900390L (en) 1990-08-02
NZ232356A (en) 1991-10-25
DE69024672T2 (de) 1996-08-14
DE69024672D1 (de) 1996-02-22
AU4907290A (en) 1990-08-09
GB8902300D0 (en) 1989-03-22
EP0381522A1 (fr) 1990-08-08

Similar Documents

Publication Publication Date Title
AU652337B2 (en) Spray preparations for respiratory tract infections
MY106730A (en) Zinc spray preparations.
USD305262S (en) Nasal aspirator
CA2115348A1 (fr) Methode de production de preparations pharmaceutiques injectables ou perfusables contenant des proteines humaines
CA2146635A1 (fr) Rince-bouche concentre pour la liberation efficace d'agents antimicrobiens
CA2160366A1 (fr) Pamoate de risperidone
AU2250788A (en) Respiratory mask
CA2156408A1 (fr) Formulation d'aerosol contenant un agent dispersant
GR3002480T3 (en) Condom
HU9700060D0 (en) New compound, it's production and it's use as active component of a medicine
CA2194549A1 (fr) Projectile d'entrainement
CA2018791A1 (fr) Compose capillaire
AU8268491A (en) Phosphonopyrrolidine- and piperidine-containing pseudopeptides of the statin type, a process for their preparation and their use as medicaments against retroviruses
CA2144416A1 (fr) Methode et composition pour empecher la perte des cheveux
USD269374S (en) Ammonia inhalant package
EP0207505A3 (fr) Utilisation d'un prényl cétone dans la préparation d'un médicament contre la gastrite
IL110685A0 (en) Microparticles, processes for their preparation and their use for the preparation of medicaments
CA2034926A1 (fr) Methode et compositions pour le traitement des intoxications
World Health Organization Programme for the Control of Acute Respiratory Infections: fifth programme report, 1990-1991
AU684260B2 (en) 1,4-benzoxazine-2-acetic acid compound, process for producing the same, and use thereof
CA2101548A1 (fr) Acides acylamino-alylidenehydroxy-bisphosphoniques, utiles pour le traitement des maladies osteoarticulaires
USD282496S (en) Resuscitator for newborn pigs
CA2057456A1 (fr) Produit pharmaceutique contre la depression
USD276140S (en) Bottle top
ZA968315B (en) Administration by inhalation of 2-amino-6n-propyl-amino-4,5,,7-tetrahydrobenzothiazole particularly the (-)-enan-tiomer thereof and the pharmacologically acceptable acid addition salts thereof

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed